Optimizing Treatment in Pulmonary Edema and Infection Control Measures

Discussion of high versus low dose nitroglycerin in pulmonary edema patients, challenges in treating catecholamine-related acute pulmonary syndrome, and the necessity of proper blinded trials for practice change. Also, evaluation of the effectiveness and practical implications of contact precautions for preventing healthcare-associated infections, focusing on MRSA and challenges with PPE guidelines during the COVID period.